More than 6 million Americans suffer from heart failure - about 10% of those patients suffer from advanced heart failure. These patients can no longer be treated with conventional heart therapies and symptom management strategies. As a result, a more targeted and invasive technique needs to be discussed and decided between the patient and their doctor.
This book describes the current state of the art in mechanical circulatory support with an emphasis in patient selection, device selection, management of comorbidities and complications. The book is the first authoritative and comprehensive volume dedicated to how the technology can be used safely to benefit ill patients suffering from advanced heart failure.
The book begins with a brief historical perspective of the technology and its development. It will be divided in 6 sections with multiple chapters, each addressing a specific area in MCS. These sections include types of support, the MCS program, patient selection, operative techniques, management, complications, and special considerations. Chapter authors are experts in their fields.
Mechanical Heart Assistance to Heart Replacement: A Guide is an essential reference for all providers (physician, nurses, coordinators, engineers, industry, hospitals and regulatory agencies) who manage patients with advanced heart failure who require mechanical circulatory support.

The first authoritative volume dedicated to technology in advanced heart failure

Offers a broad overview of the current technology

Gives the expertise of dozens of experts in the field

Inhalt
1 History, Science and Early DevelopmentSection 1: Types of Support 2 Extra-Corporeal Membrane Oxygenation: Indications and Use3 Early Concepts VADs: First & Second Generations4 Short-term Support: Abiomed Concepts5 Short-term Support Tandem Heart Concept6 HeartMate II and Axial Flow Pumps VADs7 HeartWare LVAD8 HeartMate 39 Future LVADs Concepts10 Why an Artificial Heart?11 SynCardia Total Artificial Heart12 Carmat Total Artificial Heart13 Bivacor Total Artificial Heart and Future ConceptsSection 2: MCS Programs 14 The MCS Coordinator's Role15 The Team Concept: What you need16 Regulatory Agencies around the world17 MCS Registries; INTERMACS and IMACS18 Ethical Considerations and Palliative Care in MCS19 Physical Rehabilitation before and after MCS20 Quality of Life Metrics and Limits21 Patient, Religion and the Provider22 The Social Worker and Pre-implantation assessmentSection 3: Patient Selection 23 Univentricular vs. Biventricular Failure: The Decision24 Choose short- vs. long-term support and when to transition25 LVADs, BiVADS and TAHs26 Age, Frailty and Nutrition27 Comorbid Conditions Influencing MCS28 Women and MCS29 The Pediatric Population: Selection, devices and outcomes30 The Cachectic and the Morbidly Obese PatientsSection 4: Techniques 31 Techniques for Short-Term Devices32 Thoracotomy vs. Sternotomy33 Anesthesia for MCS34 Echocardiography for VADs and TAHs35 The Role of the Perfusionists in MCS36 ICU Care in the care of the MCS PatientSection 5: Management and Complications 37 The Role of Protocols for the Management of Complications38 Anticoagulation: what, when, how much and for how long?39 Acquired von Willebrand Factor Disorder and management40 Neurologic Complications41 Pulmonary Complications42 Right Ventricular Failure after LVAD placement43 Cardiac complications and Arrhythmias 44 Aortic Valve Acquired Disorders and Management45 Hepatic Dysfunction post MCS46 Renal Dysfunction and Dialysis after MCS47 Infectious Complications48 Immunologic Disorders after MCS49 Gastrointestinal Bleeding50 Pump ThrombosisSection 6: Special Considerations 51 Patient and Family Education: (The Burden)52 The Role of the Psychiatrist and Support53 Outpatient Management of the MCS Patient54 Recovery, Transplantation, Destination or Anything?55 Pulsatile vs. Non-pulsatile flow56 MCS in other countries